CSL Behring Commitment
CSL Behring offers many programs and services to the bleeding disorders community,
in addition to its range of blood products. Check out this wide variety of resources:
Reimbursement Resources Center
Call 1-800-676-4266 for expert advice and information about insurance
matters, including health insurance reimbursement for CSL Behring products.
Patient Assistance Program
This program provides medically necessary therapies to qualified patients who are
uninsured, underinsured, or who cannot afford their prescribed therapy.
CSL Behring AssuranceSM
A lapse in insurance coverage can happen—and it can be scary. CSL Behring AssuranceSM
helps people who rely on Humate-P to continue to receive treatment
during a lapse in third-party private health insurance.
Important Safety Information
Antihemophilic Factor/von Willebrand Factor Complex (Human), Humate-P® is approved
to treat and prevent bleeding in adult patients with hemophilia A (classical hemophilia).
Humate-P also treats spontaneous or trauma-induced bleeding episodes in adults and
children with von Willebrand disease (VWD) and prevents excessive bleeding during and
after surgery in patients with mild, moderate or severe VWD. Humate-P is not known to
prevent spontaneous bleeding episodes.
Do not take Humate-P if you have had extreme sensitivity or an allergic response to
antihemophilic or von Willebrand factor preparations. Your doctor will monitor you for
events related to abnormal blood clotting.
Humate-P is made from human blood and could contain infectious agents. The risk that
these agents may transmit disease cannot be completely eliminated, but has been reduced
by screening plasma donors and testing donated plasma for certain viruses, and by
inactivating and/or removing viruses during manufacturing.
In studies, more than 5% of patients reported the following adverse reactions to Humate-P: allergic/anaphylactic reactions, including hives, chest tightness, rash, itching, and swelling. The most common adverse reactions after surgery were bleeding at the wound
or infusion site, and nosebleeds.
Please see full prescribing information.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.